Cisplatin nephrotoxicity affects magnesium and calcium metabolism

Authors


  • Presented at the 7th International Conference on the Long-Term Complications of Treatment of Children and Adolescents for Cancer.

Abstract

Cisplatin is not directly toxic to bone, but cisplatin nephrotoxicity leading to magnesium wasting may affect magnesium and calcium metabolism, both of which contribute to bone integrity. The specificity of the magnesium lesion suggests that cisplatin may have an affinity for proteins that regulate magnesium absorption. Sulfhydryls such as amifostine can reduce the toxicity of cisplatin in adults, but current pediatric data do not indicate a role for sulfhydryl therapy to reduce cisplatin toxicity in children. Med Pediatr Oncol 2003;41:186–189, © 2003 Wiley-Liss, Inc.

Ancillary